China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析

◆英語タイトル:China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2909
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

China Chemical & Pharmaceutical Co Ltd (1701) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China Chemical & Pharmaceutical Co Ltd (CCPC) is a pharmaceutical company which carries out research and development and contract manufacturing of pharmaceutical products for human and animal healthcare. CCPC manufactures prescription and over-the-counter (OTC) drugs that focus on the treatment of chronic cardiovascular diseases and metabolic disorders, acute infections, psychiatric disorders, allergies and respiratory disorders. It also manufactures animal drugs, non-medical feed additives and health foods those for poultry, pigs, cows and companion animals. The company partners with animal drugs distributors in China to market its niche products in the Chinese market. CCPC is headquartered at Taipei, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
China Chemical & Pharmaceutical Co Ltd – Key Facts 5
China Chemical & Pharmaceutical Co Ltd – Key Employees 6
China Chemical & Pharmaceutical Co Ltd – Major Products and Services 7
China Chemical & Pharmaceutical Co Ltd – History 9
China Chemical & Pharmaceutical Co Ltd – Company Statement 10
China Chemical & Pharmaceutical Co Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Company Overview 13
China Chemical & Pharmaceutical Co Ltd – Business Description 14
China Chemical & Pharmaceutical Co Ltd – SWOT Analysis 15
SWOT Analysis – Overview 15
China Chemical & Pharmaceutical Co Ltd – Strengths 15
China Chemical & Pharmaceutical Co Ltd – Weaknesses 17
China Chemical & Pharmaceutical Co Ltd – Opportunities 18
China Chemical & Pharmaceutical Co Ltd – Threats 19
China Chemical & Pharmaceutical Co Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
China Chemical & Pharmaceutical Co Ltd, Recent Deals Summary 29
Section 5 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
China Chemical & Pharmaceutical Co Ltd, Key Facts 5
China Chemical & Pharmaceutical Co Ltd, Key Employees 6
China Chemical & Pharmaceutical Co Ltd, Major Products and Services 7
China Chemical & Pharmaceutical Co Ltd, History 9
China Chemical & Pharmaceutical Co Ltd, Other Locations 11
China Chemical & Pharmaceutical Co Ltd, Subsidiaries 12
China Chemical & Pharmaceutical Co Ltd, Key Competitors 20
China Chemical & Pharmaceutical Co Ltd, Ratios based on current share price 21
China Chemical & Pharmaceutical Co Ltd, Annual Ratios 22
China Chemical & Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 23
China Chemical & Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 24
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
China Chemical & Pharmaceutical Co Ltd, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures
China Chemical & Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 25
China Chemical & Pharmaceutical Co Ltd, Ratio Charts 26
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Independent News & Media Plc:企業の戦略的SWOT分析
    Independent News & Media Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Venture Global LNG Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Venture Global LNG Inc (VGLI) is an exporter of american-produced liquefied natural gas. The company owns and manages two Louisiana-based export projects Calcasieu Pass and Plaquemines. The company through subsidiary Venture Global Calcasieu Pass, LLC, operates Calcasieu Pass project, which …
  • Petrosibir AB (SHEL B):企業の財務・戦略的SWOT分析
    Summary Petrosibir AB (Petrosibir), formerly Shelton Petroleum AB is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • Singulus Technologies AG (SNG):企業の財務・戦略的SWOT分析
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Heptares Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Heptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise S …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bharat Petroleum Corp Ltd (BPCL):石油・ガス:M&Aディール及び事業提携情報
    Summary Bharat Petroleum Corp Ltd (BPCL) is an integrated oil and gas company. It carries out production of oil and natural gas; refining of crude oil; and marketing and distribution of petroleum products. The company also focuses on renewable energy. It produces oil products including light distill …
  • Medidata Solutions Inc (MDSO)-医療機器分野:企業M&A・提携分析
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • The American Energy Group Ltd (AEGG):企業の財務・戦略的SWOT分析
    Summary The American Energy Group Ltd (American Energy Group), is an oil and natural gas company that develops, explores, acquire, and produces oil and natural gas producing assets. The company owns interest in two oil and gas leases in Southeast Texas American Energy Group's portfolio consists of e …
  • Woolworths Limited:戦略・SWOT・企業財務分析
    Woolworths Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • United Technologies Corp (UTX):電力:M&Aディール及び事業提携情報
    Summary United Technologies Corp (UTC) is a provider of technology products and services for applications in the aerospace and building systems industries. The company’s building systems portfolio includes elevators and escalators, moving walkways, heating, ventilating, air conditioning (HVAC) and r …
  • Kerecis ehf:医療機器:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • Bloomin’ Brands Inc:企業の戦略・SWOT・財務分析
    Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report Summary Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cloverdale Paint Inc:企業の戦略的SWOT分析
    Cloverdale Paint Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Dabur India Limited:戦略・SWOT・企業財務分析
    Dabur India Limited - Strategy, SWOT and Corporate Finance Report Summary Dabur India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆